Covid-19: a French researcher reports on a successful drug trial
According to connexionfrance.com, Professor Didier Raoult of the l’Institut Hospitalo-Universitaire hospital (IHU Mediterranee), published a video to explain the trials carried out earlier this week.
More about Covid-19
Raoult, an infectious disease specialist, was tasked with the French government investigating a possible treatment for the new coronavirus.
According to the professor, the first Covid-19 patients who treated with the drug chloroquine saw a rapid and effective acceleration of their healing process, and a sharp decrease in the amount of time they remained contagious.
Chloroquine, which is normally used to prevent and treat malaria, was administered through the drug Plaquenil.
“We included everyone who agreed to be treated, which was almost everyone. Two cities in the protocol, Nice and Avignon, gave us infected patients who had not yet received treatment,” said Raoult, quoted by connexionfrance.com.
According to the media report, the treatment was offered to 24 patients, who were among the first to become infected in south-eastern France, and who had voluntarily entered the hospital for the process.
Patients received 600 mcg per day for 10 days. They were closely monitored as the drug can interact with other drugs and cause serious side effects in some cases, he added.
“We were able to determine that patients who had not received Plaquenil (a drug containing hydroxychloroquine) were still contagious after six days, but of those who received Plaquenil, only 25 percent were still contagious after the given period,” he added.
Chloroquine phosphate and hydroxychloroquine have previously been used to treat patients with coronavirus in China, in ongoing clinical trials of Covid-19.
Kaletra, a US-based antiviral medication. USA Used to treat HIV, it is another drug that is being tested in the fight against the deadly virus.